Drawing for IONIS

USPTO serial 99666317

IONIS

Reviewed by CopyMark Law Group

Status 819
Filing date
Status date
Registration date
—
Examiner
PAQUIN, SAMUEL ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IONIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian J. Focarino

Brian J. Focarino Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700IP Docketing DepartmentWashington, DC 20004-2400

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances, biological preparations and substances, therapeutic preparations and substances, namely, nucleic acid-targeted therapeutics; Pharmaceutical preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Biological preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Therapeutic preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disordersACTIVEAug 28, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 26, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 26, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 25, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 24, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 24, 2026EX1GSOU EXTENSION 1 GRANTED—
Sep 25, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 10, 2026IUAFUSE AMENDMENT FILED—
Aug 10, 2026EXT1SOU EXTENSION 1 FILED—
Aug 10, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 10, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 30, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 5, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 5, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2026DOCKASSIGNED TO EXAMINER—
Feb 23, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 23, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance